Perrigo has announced a £2.4 million investment in Dermalex in 2018. A television campaign focusing on Dermalex’s eczema treatment will be on air for six weeks from 19 February, supported with paid social content across Facebook and Instagram. Subsequent activity in April will focus on rosacea for eight weeks and include advertising in national newspapers and magazines, with a third peak of activity in September for 12 weeks. During these peaks, POS and training materials focusing on these skin conditions will be rolled out to pharmacies to support pharmacy staff and increase their understanding of when and how to recommend Dermalex products, explains Perrigo.

Perrigo: 0800 1216 909

Recommended

Success for TENA

TENA Lady Discreet has been recognised as the UK’s best bladder weakness range after being named Product of the Year f...

New contraception option from Bayer

A new long-acting reversible contraception method offering protection from unplanned pregnancy for up to five years has ...